Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Dennie Jones"'
Autor:
Grace Ann Hanvey PhD, Elizabeth L. Kacel PhD, Kelsey C. Bacharz MA, Adaixa Padrón Wilborn PhD, Sonia Mesa, Halle McCracken MA, Irene M. Estores MD, Merry-Jennifer Markham MD, Frederic J. Kaye MD, Dennie Jones MD, Thomas J. George MD, Deidre B. Pereira PhD
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Background: Fear of cancer recurrence (FCR), cancer-distress, depression, and anxiety are prevalent concerns among women with gynecologic and other understudied cancers, especially among women of color and lower socioeconomic status (SES). Evidence i
Externí odkaz:
https://doaj.org/article/5279212c4f9d4168b6493686b8d41794
Autor:
Emily J. Cicali, Elizabeth Eddy, Yan Gong, Amanda L. Elchynski, Kim Pena del Aguila, Tala Basha, Karen C. Daily, Lauren Dickson, Steven Fischer, Erin Hastings‐Monari, Dennie Jones Jr., Brian H. Ramnaraign, David L. DeRemer, Thomas J. George, Rhonda M. Cooper‐DeHoff
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)
Abstract The University of Florida Health conducted a pragmatic implementation of a pharmacogenetics (PGx) panel‐based test to guide medications used for supportive care prescribed to patients undergoing chemotherapy. The implementation was in the
Externí odkaz:
https://doaj.org/article/6ba77f494cb54183b06d4c9b1083c926
Autor:
Emiliano Calvo Aller, Glenn Hanna, Maria Vieito Villar, Caroline Even, Victor Moreno, Chul Kim, Shuchi Gulati, Daniel Morgensztern, Ana Acuna-Villaorduna, Philippe Cassier, Dennie Jones, Florilene Bouisset, Daniela Sahlender, Elisabeth Rouits, Dany Spaggiari, Lars Damstrup, Carlos-Alberto Gomez-Roca
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2028b5fbd64c167f25d424f7354d7b84
https://doi.org/10.1136/jitc-2022-sitc2022.0589
https://doi.org/10.1136/jitc-2022-sitc2022.0589
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4271ecc3efcd740a0ebafac42c9085de
https://doi.org/10.7759/cureus.26323
https://doi.org/10.7759/cureus.26323
Autor:
Thomas J. George, Dennie Jones, Zeina Al-Mansour, Jonathan Alexander Chatzkel, Brian Hemendra Ramnaraign, David L. DeRemer, Sherise C. Rogers
Publikováno v:
JCO Oncology Practice. 17:240-245
Patients with autoimmune disorders, multiple comorbidities, poor performance status, advanced age, and infection with SARS-CoV-2 (COVID-19) each represent unique subgroups of patients with cancer to whom little is known of the effects, benefits, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::342286a531f76dc8c26c826384e5f1aa
https://doi.org/10.1200/op.20.00996
https://doi.org/10.1200/op.20.00996
Autor:
Richard J. Marrero, Taimour Y. Langaee, Elizabeth M. Eddy, Meghan J. Arwood, Kimberly J. Newsom, Brian Hemendra Ramnaraign, Michael J. Clare-Salzer, Karen Daily, Rhonda M. Cooper-DeHoff, David L. DeRemer, Petr Starostik, Dennie Jones, Emily J. Cicali, Julie A. Johnson, Thomas J. George, Kelsey J. Cook, Larisa H. Cavallari, Kristin Weitzel
Publikováno v:
Clin Pharmacol Ther
There have been significant advancements in precision medicine and approaches to medication selection based on pharmacogenetic results. With the availability of direct-to-consumer genetic testing and growing awareness of genetic interindividual varia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa5d084998a1b4dfa8295e8641fc3ed
https://doi.org/10.1002/cpt.1912
https://doi.org/10.1002/cpt.1912
Autor:
Robert Hromas, Thomas J. George, Nasreen Najmunnisa, Gayathri Srinivasan, Elizabeth A. Williamson, Dennie Jones, Keith M. Wilcoxen, Aruna S. Jaiswal, Gurjit S. Sidhu
Publikováno v:
Cancer Chemotherapy and Pharmacology
Malignant pleural mesotheliomas (MPM) are most often surgically unresectable, and they respond poorly to current chemotherapy and radiation therapy. Between 23 and 64% of malignant pleural mesothelioma have somatic inactivating mutations in the BAP1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9a89b59cac7948c2f30cadda375400
https://pubmed.ncbi.nlm.nih.gov/28756516
https://pubmed.ncbi.nlm.nih.gov/28756516
Autor:
Neil Clendinnin M.D., Dennie Jones, D O Richard Theriault, M.P.H. Lisa A. Newman M.D., Lori Pierce
Publikováno v:
Cancer. 97:246-252
BACKGROUND. Breast cancer mortality rates are higher among African-American women compared with white American women, yet little is known regarding ethnicity-related variation in patterns of primary surgical treatment, locoregional recurrence rates,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f6ea9794cccc8254fbf6fa54a8a80eb
https://doi.org/10.1002/cncr.11015
https://doi.org/10.1002/cncr.11015
Autor:
Joy B. Ostroff, James A. H. Murray, Hannah Brewer, Carol R. Daniel, Nicole Onetto, Albert F. LoBuglio, Diane Healey, Mansoor N. Saleh, Donna LeBherz, Steve Sugarman, Dennie Jones
Publikováno v:
Journal of Clinical Oncology. 18:2282-2292
PURPOSE: We conducted a phase I clinical trial of BR96-Doxorubicin (BR96-Dox), a chimeric anti–Lewis Y (LeY) monoclonal antibody conjugated to doxorubicin, in patients whose tumors expressed the LeY antigen. The study aimed to determine the toxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ae6a7271df3447c357b13c115403b08
https://doi.org/10.1200/jco.2000.18.11.2282
https://doi.org/10.1200/jco.2000.18.11.2282
Autor:
Irena Sniecinski, Jeffrey Longmate, Stephen J. Forman, Warren Chow, Stephen Shibata, Mark Ashby, Gaylord J. Knutson, Lucille Leong, Merry Tetef, Susan Hellmann, Yun Yen, James Raschko, Anna ter Veer, George Somlo, Robert J. Morgan, Ravi Bhatia, Gwen Fyfe, James H. Doroshow, Stanimir Vuk-Pavlović, Dennie Jones, Kim Margolin
Publikováno v:
Blood. 93:2798-2806
Lineage-specific growth factors mobilize peripheral blood progenitor cells (PBPC) and accelerate hematopoietic recovery after high-dose chemotherapy. Recombinant human thrombopoietin (rhTPO) may further increase the progenitor-cell content and regene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab58c06620e9b3208109247b76264a15
https://doi.org/10.1182/blood.v93.9.2798
https://doi.org/10.1182/blood.v93.9.2798